Literature DB >> 30177518

Neonatal Antibiotic Use: How Much Is Too Much?

Dustin D Flannery1, Karen M Puopolo2.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 30177518      PMCID: PMC6317556          DOI: 10.1542/peds.2018-1942

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  27 in total

1.  Choriophobia: a 1-act play.

Authors:  James A Taylor; Douglas J Opel
Journal:  Pediatrics       Date:  2012-07-09       Impact factor: 7.124

2.  Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death.

Authors:  Reese H Clark; Barry T Bloom; Alan R Spitzer; Dale R Gerstmann
Journal:  Pediatrics       Date:  2006-01       Impact factor: 7.124

3.  The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.

Authors:  C Michael Cotten; Scott McDonald; Barbara Stoll; Ronald N Goldberg; Kenneth Poole; Daniel K Benjamin
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

4.  Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit.

Authors:  Chia-Hua Chiu; Ian C Michelow; Jonathan Cronin; Steven A Ringer; Timothy G Ferris; Karen M Puopolo
Journal:  Pediatr Infect Dis J       Date:  2011-04       Impact factor: 2.129

5.  Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants.

Authors:  Leandro Cordero; Leona W Ayers
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

6.  Neonatal antibiotic treatment is a risk factor for early wheezing.

Authors:  Bernt Alm; Laslo Erdes; Per Möllborg; Rolf Pettersson; S Gunnar Norvenius; Nils Aberg; Göran Wennergren
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

7.  Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation.

Authors:  Gabriel J Escobar; Karen M Puopolo; Soora Wi; Benjamin J Turk; Michael W Kuzniewicz; Eileen M Walsh; Thomas B Newman; John Zupancic; Ellice Lieberman; David Draper
Journal:  Pediatrics       Date:  2013-12-23       Impact factor: 7.124

8.  Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants.

Authors:  C Michael Cotten; Sarah Taylor; Barbara Stoll; Ronald N Goldberg; Nellie I Hansen; Pablo J Sánchez; Namasivayam Ambalavanan; Daniel K Benjamin
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

Review 9.  Health care-associated infections in the neonatal intensive care unit: barriers to continued success.

Authors:  Matthew J Bizzarro
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

Review 10.  Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit.

Authors:  Sameer J Patel; Lisa Saiman
Journal:  Semin Perinatol       Date:  2012-12       Impact factor: 3.300

View more
  3 in total

1.  Reducing Early Antibiotic Use: A Quality Improvement Initiative in a Level III Neonatal Intensive Care Unit.

Authors:  Catalina Morales-Betancourt; Javier De la Cruz-Bértolo; Bárbara Muñoz-Amat; Elena Bergón-Sendín; Carmen Pallás-Alonso
Journal:  Front Pediatr       Date:  2022-05-31       Impact factor: 3.569

2.  Palliative care and infection management at end of life in nursing homes: A descriptive survey.

Authors:  Aluem Tark; Leah V Estrada; Mary E Tresgallo; Denise D Quigley; Patricia W Stone; Mansi Agarwal
Journal:  Palliat Med       Date:  2020-03-10       Impact factor: 4.762

3.  Influence of Patient Characteristics on Antibiotic Use Rates Among Preterm Infants.

Authors:  Dustin D Flannery; Sagori Mukhopadhyay; Erik A Jensen; Jeffrey S Gerber; Molly R Passarella; Kevin Dysart; Zubair H Aghai; Jay Greenspan; Karen M Puopolo
Journal:  J Pediatric Infect Dis Soc       Date:  2021-03-26       Impact factor: 3.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.